Search Results - jin-xiong+she

4 Results

Sort By:

The current state of the art:Gliomas account for about 27% of all brain tumors and about 80% of the malignant tumors. Currently, Glioma is classified by histology and the gene mutation test (isocitrate dehydrogenase, IDH) defined by the world health organization (WHO).The problems with the current art:However, there is a big discrepancy between histology...

Published: 4/7/2023 | Inventor(s): Jin-Xiong She, Paul Tran

Keywords(s):

Category(s): Diagnostics

A Novel SUMO-like Gene for Type 1 Diabetes Susceptibility

Current State of the Art: Type 1 diabetes is an organ-specific autoimmune disease with aberrant immune responses to specific β-cell autoantigens. Prevention is important because diabetes interrupts normal development in children and carries the threat of severe complications in the most active period of life. Both environmental and genetic...

Published: 4/28/2020 | Inventor(s): Jin-Xiong She, Cong-Yi Wang

Keywords(s): Diabetes II, Genomics

Category(s): Diagnostics

Stat5b transgenic lymphoma mouse model and therapeutic strategies

Current State of the Art:Based on the age of the patient and the stage of lymphoma different regimens of radiation and chemotherapy are employed. In regard to drugs, most patients with early stage lymphoma are treated with a cocktail called "ABVD" chemotherapy, which contains the drugs Adriamycin (doxorubicin), bleomycin, vinblastine and dacarbazine....

Published: 8/13/2019 | Inventor(s): Jin-Xiong She, Bo Chen

Keywords(s):

Category(s): Therapeutics

Novel synergistic combinations for cancer therapy

AU researchers have discovered several drug resistance genes that can be potentially used as therapeutic targets for cancer treatment. We also describe synergistic combinations between these genes and a large number of anticancer drugs that have been approved by the FDA for clinical use or clinical trials. Therefore, these genes alone or in combination...

Published: 11/12/2021 | Inventor(s): Jin-Xiong She, Robert Schleifer, Shuchun Li

Keywords(s):

Category(s): Therapeutics